Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition

Hepatology

Volumn 49, Issue 1, 2009, Pages 185-194

  Sohail, Muhammad A ^a   Hashmi, Ardeshir Z ^a   Hakim, Wyel ^a   Watanabe, Azuma ^a   Zipprich, Alexander ^a   Groszmann, Roberto J ^a   Dranoff, Jonathan A ^a   Torok, Natalie J ^b   Mehal, Wajahat Z ^a,c  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOTHELIN 1; LYSOPHOSPHATIDIC ACID; RHO FACTOR; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; LYSOPHOSPHOLIPID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL LINE; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; LIVER STELLATE CELL; MALE; MOUSE; MUSCLE FIBER CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; STELLATE CELL; STRESS FIBER; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; ITO CELL; METABOLISM; PHYSIOLOGY;

ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANIMALS; CELL LINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENDOTHELIN-1; HEPATIC STELLATE CELLS; HUMANS; LYSOPHOSPHOLIPIDS; MALE; MICE; RATS; RECEPTOR, ADENOSINE A2A; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; STRESS FIBERS;

EID: 58949088374     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22589     Document Type: Article

References (36)

1. Rockey DC, Housset CN, Friedman SL. Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J Clin Invest 1993;92: 1795-1804.
2. Kawada N, Klein H, Decker K. Eicosanoid-mediated contractility of hepatic stellate cells. Biochem J 1992;285:367-371.
3. Sakamoto M, Ueno T, Kin M, Ohira H, Torimura T, Inuzuka S, et al. Ito cell contraction in response to endothelin-1 and substance P. HEPATOLOGY 1993;18:978-983.
4. Pinzani M, Failli P, Ruocco C, Casini A, Milani S, Baldi E, et al. Fatstoring cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients. J Clin Invest 1992;90:642-646.
5. Bataller R, Nicolas JM, Gines P, Esteve A, Nieves Gorbig M, Garcia-Ramallo E, et al. Arginine vasopressin induces contraction and stimulates growth of cultured human hepatic stellate cells. Gastroenterology 1997; 113:615-624.
6. Rockey DC. Hepatic fibrosis, stellate cells, and portal hypertension. Clin Liver Dis 2006;10:459-479.
7. Chan ES, Montesinos MC, Fernandez P, Desai A, Delano DL, Yee H, et al. Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis. Br J Pharmacol 2006;148:1144-1155.
8. Che J, Chan ES, Cronstein BN. Adenosine A2A receptor occupancy stimulates collagen expression by hepatic stellate cells via pathways involving protein kinase A, Src, and extracellular signal-regulated kinases 1/2 signaling cascade or p38 mitogen-activated protein kinase signaling pathway. Mol Pharmacol 2007;72:1626-1636.
9. Chunn JL, Mohsenin A, Young HW, Lee CG, Elias JA, Kellems RE, et al. Partially adenosine deaminase-deficient mice develop pulmonary fibrosis in association with adenosine elevations. Am J Physiol Lung Cell Mol Physiol 2006;290:L579-L587.
10. Gao ZG, Jacobson KA. Emerging adenosine receptor agonists. Expert Opin Emerg Drugs 2007;12:479-492.
11. Hashmi AZ, Hakim W, Kruglov EA, Watanabe A, Watkins W, Dranoff JA, et al. Adenosine inhibits cytosolic calcium signals and chemotaxis in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2007;292: G395-G401.
12. Lee JS, Kang Decker N, Chatterjee S, Yao J, Friedman S, Shah V. Mechanisms of nitric oxide interplay with Rho GTPase family members in modulation of actin membrane dynamics in pericytes and fibroblasts. Am J Pathol 2005;166:1861-1870.
13. Yanase M, Ikeda H, Matsui A, Maekawa H, Noiri E, Tomiya T, et al. Lysophosphatidic acid enhances collagen gel contraction by hepatic stellate cells: Association with rho-kinase. Biochem Biophys Res Commun 2000; 277:72-78.
14. Liu C, Gaca MD, Swenson ES, Vellucci VF, Reiss M, Wells RG. Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent. J Biol Chem 2003;278:11721-11728.
15. Kawada N, Seki S, Kuroki T, Kaneda K. ROCK inhibitor Y-27632 attenuates stellate cell contraction and portal pressure increase induced by endothelin-1. Biochem Biophys Res Commun 1999;266:296-300.
16. Burridge K, Wennerberg K. Rho and Rac take center stage. Cell 2004;116: 167-179.
17. Yee HF Jr. Rho directs activation-associated changes in rat hepatic stellate cell morphology via regulation of the actin cytoskeleton. HEPATOLOGY 1998;28:843-850.
18. Murata T, Arii S, Nakamura T, Mori A, Kaido T, Furuyama H, et al. Inhibitory effect of Y-27632, a ROCK inhibitor, on progression of rat liver fibrosis in association with inactivation of hepatic stellate cells. J Hepatol 2001;35:474-481.
19. Lang P, Gesbert F, Delespine-Carmagnat M, Stancou R, Pouchelet M, et al. Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes. EMBO J 1996;15:510-519.
20. Sawada N, Itoh H, Yamashita J, Doi K, Inoue M, Masatsugu K, et al. cGMP-dependent protein kinase phosphorylates and inactivates RhoA. Biochem Biophys Res Commun 2001;280:798-805.
21. Aktories K. Bacterial toxins that target Rho proteins. J Clin Invest 1997; 99:827-829.
22. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, et al. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 1996;271:20246-20249.
23. Nakamura M, Nagano T, Chikama T, Nishida T. Role of the small GTP-binding protein rho in epithelial cell migration in the rabbit cornea. Invest Ophthalmol Vis Sci 2001;42:941-947.
24. Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC. Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 2006;112:358-404.
25. Cronstein BN. Adenosine receptors and wound healing. Scientific World-Journal 2004;4:1-8.
26. Chen JF, Sonsalla PK, Pedata F, Melani A, Domenici MR, Popoli P, et al. Adenosine A2A receptors and brain injury: Broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation. Prog Neurobiol 2007;83:310-331.
27. DiFrancesco D, Borer JS. The funny current: Cellular basis for the control of heart rate. Drugs 2007;67(Suppl 2):15-24.
28. Baorto DM, Mellado W, Shelanski ML. Astrocyte process growth induction by actin breakdown. J Cell Biol 1992;117:357-367.
29. Ramakers GJ, Moolenaar WH. Regulation of astrocyte morphology by RhoA and lysophosphatidic acid. Exp Cell Res 1998;245: 252-262.
30. Kato M, Iwamoto H, Higashi N, Sugimoto R, Uchimura K, Tada S, et al. Role of Rho small GTP binding protein in the regulation of actin cytoskeleton in hepatic stellate cells. J Hepatol 1999;31:91-99.
31. Morimoto Y, Wettstein M, Haussinger D. Hepatocyte heterogeneity in response to extracellular adenosine. Biochem J 1993;293:573-581.
32. Buxton DB, Fisher RA, Robertson SM, Olson MS. Stimulation of glycogenolysis and vasoconstriction by adenosine and adenosine analogues in the perfused rat liver. Biochem J 1987;248:35-41.
33. Champigneulle B, Braillon A, Kleber G, Gaudin C, Cailmail S, Lebrec D. Adenosine and hemodynamic alterations in cirrhotic rats. Am J Physiol 1991;260:G543-G547.
34. Kleber G, Steudel N, Behrmann C, Zipprich A, Hubner G, Lotterer E, et al. Hepatic arterial flow volume and reserve in patients with cirrhosis: use of intraarterial Doppler and adenosine infusion. Gastroenterology 1999;116:906-914.
35. Zipprich A. Hemodynamics in the isolated cirrhotic liver. J Clin Gastroenterol 2007;41:S254-S258.
36. Zipprich A, Steudel N, Behrmann C, Meiss F, Sziegoleit U, Fleig WE, et al. Functional significance of hepatic arterial flow reserve in patients with cirrhosis. HEPATOLOGY 2003;37:385-392.